Is Palbociclib available from Qilu Pharmaceutical?

Palbociclib (Palbociclib) is a domestic drug produced by Qilu Pharmaceutical Company. It has been approved by the State Food and Drug Administration for marketing. Its pharmaceutical ingredients are basically the same as those of the original drug of Palbociclib. It is mainly used to treat breast cancer. It is understood that the price of each box may be more than 4,000 yuan. Palbociclib has entered the category B category. Purchase of this drug can be reimbursed by medical insurance.

Palbociclib is a targeted therapy calledCDK 4/6 inhibitor, which is not traditional chemotherapy. Combined with certain hormone therapies, palbociclib can inhibit the growth of both healthy cells and cancer cells. Palbociclib represents hormone receptor-positive (HR+) icon, human epidermal growth factor receptor 2-negative (HER2-) icon metastatic breast cancer (MBC), including breast cancer that has spread to other parts of the body, or HR+/HER2- mBC. Palbociclib helps slow the growth of cancer, but can also cause side effects, some of which are serious, such as neutropenia, infections, anemia, and more.

The specifications of palbociclib's original drug marketed overseasThe price of 125mg*21 capsules per box may bearound RMB 10,000 (the price may fluctuate due to exchange rates). There are also generic palbociclib drugs produced in other countries. The specifications produced by Bangladesh Pharmaceutical FactoryThe price of 125mg*21 pills per box may be around 900 yuan (the price may fluctuate due to the exchange rate), which is cheaper. The pharmaceutical ingredients of generic drugs are basically the same as those of domestic and foreign original drugs. For more drug information and specific prices, please consult the medical consultant of Yaode.